(Total Views: 612)
Posted On: 05/02/2021 10:23:56 AM
Post# of 153908
Have a link?? TIA.
Given all the disease indications where CCR5 is overexpressed and given the LL MoA which minimizes or neutralizes CCR5 I am really beginning to wonder (hope) that LL's modulation of CCR5 might actually prove itself as a protection against cancer events in those who regularly medicate with LL. I have read this idea here before. I am hoping that CYDY's HIV patients, given all their other troubles might somehow have become a favored populations re: cancer. JMHO
Given all the disease indications where CCR5 is overexpressed and given the LL MoA which minimizes or neutralizes CCR5 I am really beginning to wonder (hope) that LL's modulation of CCR5 might actually prove itself as a protection against cancer events in those who regularly medicate with LL. I have read this idea here before. I am hoping that CYDY's HIV patients, given all their other troubles might somehow have become a favored populations re: cancer. JMHO
(6)
(0)
